Plastic surgeon on TikTok and GLP-1s: separating the surgical from the speculative

What did @austinplasticsurgeon actually say?

The creator presented a before-and-after case of a patient who lost significant weight on a GLP-1 medication and ended up with what they called a "Ozempic butt" or "zepig butt," meaning a flat, volume-depleted posterior with skin laxity. Their proposed fix was a combination of injectable filler (referred to as "aloe clay"), cellulite release, and skin-tightening devices like Quantum, Nouveon, Viva, or Softwave.

The core claim is that "targeted volume" plus skin tightening produces a dramatic improvement without overfilling. They explicitly framed this as not trying to create a "massive butt" but rather restoring a natural, proportionate shape. They also drew a parallel to facial rejuvenation approaches, suggesting the same principles apply to body contouring after GLP-1-related fat loss.

The creator is a self-identified plastic surgeon, so the clinical authority framing here matters. This is not a wellness influencer guessing. That context shapes how we should evaluate the advice.

Does the science back this up?

The general principle here is sound, but the specific product claims are where things get murky. Volume loss in the gluteal region after rapid weight loss is real and well-documented in the surgical literature, and the combination approach of volume restoration plus tissue tightening has legitimate support.

GLP-1-associated body composition changes are increasingly recognized in clinical practice. A 2023 analysis published in Obesity (Bikou et al.) and follow-up commentary noted that semaglutide-induced weight loss disproportionately affects lean mass and subcutaneous fat, which explains the accelerated skin laxity and volume deflation patients report. This is not a fringe observation.

The case for combining filler with energy-based skin tightening for body contouring is supported by smaller studies. Radiofrequency and ultrasound-based devices (like those in the Softwave and Viva categories) have demonstrated modest but real improvements in skin laxity in RCTs, including work by Weiss et al. (2014, Lasers in Surgery and Medicine). However, the effect sizes are modest, and "dramatic" results in the short term often reflect swelling as much as true remodeling.

The term "aloe clay" does not correspond to any named filler in the peer-reviewed literature or FDA-cleared product database. That needs to be flagged.

What did they get wrong (or right)?

Credit where it is due: the conceptual framework is reasonable. Addressing both volume and skin quality simultaneously is the right instinct, and physicians who treat only one dimension often see suboptimal outcomes. The surgeon is correct that "if you don't tighten the envelope" after adding volume, you risk worsening the appearance of laxity. That is a legitimate clinical point consistent with how combination aesthetics is practiced.

Where this gets problematic is the product language. "Aloe clay" is not a recognized medical or cosmetic filler name. It may be a brand nickname or proprietary term used in their practice, but viewers watching this video have no way to know what substance is actually being injected. Injectable treatments carry real risks, including vascular occlusion, infection, granuloma formation, and asymmetry. When a physician uses non-standard terminology for an injectable product in a public video, that obscures informed decision-making.

The "dramatic change" framing is also worth scrutinizing. Before-and-after content on social media is notoriously subject to lighting, positioning, and timing bias. There are no published outcome data on this specific combination protocol. The result shown may be real, but one case is not evidence of a generalizable treatment effect.

What should you actually know?

If you have lost significant weight on semaglutide or tirzepatide and are unhappy with changes in your body contour, you have real options. A board-certified plastic surgeon or dermatologist with body contouring experience is a reasonable starting point for evaluation. The combination approach described here, volume restoration plus energy-based skin tightening, is practiced widely and has plausible biological rationale.

However, ask any provider you consult to name the specific injectable product they plan to use, confirm its FDA clearance or approval status, and explain the known risk profile. "Aloe clay" is not a sufficient answer. Hyaluronic acid fillers, poly-L-lactic acid (Sculptra), and calcium hydroxylapatite (Radiesse) each have published safety and efficacy profiles for off-label body use. You deserve to know which one is going in your body.

Skin-tightening devices vary considerably in mechanism, evidence base, and cost. Ask for peer-reviewed data, not just before-and-after photos. And be skeptical of "dramatic" single-case results presented on social media, even from credentialed physicians. Case selection, photography, and follow-up timing all shape what you see.